Practice guidelines, clinical trials, and unexpected results in cystic fibrosis

Ann Am Thorac Soc. 2014 Mar;11(3):402-3. doi: 10.1513/AnnalsATS.201401-023ED.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Azithromycin / pharmacology*
  • Cystic Fibrosis / complications*
  • Female
  • Humans
  • Male
  • Pseudomonas Infections / drug therapy*
  • Pseudomonas aeruginosa*
  • Tobramycin / antagonists & inhibitors*

Substances

  • Anti-Bacterial Agents
  • Azithromycin
  • Tobramycin